Mutual of America Capital Management LLC Reduces Holdings in Progyny, Inc. (NASDAQ:PGNY)

Mutual of America Capital Management LLC trimmed its stake in Progyny, Inc. (NASDAQ:PGNY) by 75.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,812 shares of the company’s stock after selling 35,620 shares during the period. Mutual of America Capital Management LLC’s holdings in Progyny were worth $198,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. RiverPark Advisors LLC grew its position in Progyny by 9.6% during the 2nd quarter. RiverPark Advisors LLC now owns 5,408 shares of the company’s stock worth $155,000 after purchasing an additional 474 shares during the last quarter. Arizona State Retirement System grew its position in Progyny by 2.6% during the 2nd quarter. Arizona State Retirement System now owns 24,313 shares of the company’s stock worth $696,000 after purchasing an additional 609 shares during the last quarter. State of New Jersey Common Pension Fund D grew its position in Progyny by 1.1% during the 2nd quarter. State of New Jersey Common Pension Fund D now owns 70,717 shares of the company’s stock worth $2,023,000 after purchasing an additional 787 shares during the last quarter. Quarry LP grew its position in Progyny by 1,900.0% during the 2nd quarter. Quarry LP now owns 880 shares of the company’s stock worth $25,000 after purchasing an additional 836 shares during the last quarter. Finally, Creative Planning grew its position in Progyny by 13.8% during the 2nd quarter. Creative Planning now owns 10,564 shares of the company’s stock worth $302,000 after purchasing an additional 1,283 shares during the last quarter. 94.93% of the stock is owned by hedge funds and other institutional investors.

Progyny Trading Up 0.6 %

Shares of PGNY opened at $15.57 on Friday. The stock has a market cap of $1.33 billion, a P/E ratio of 26.69, a PEG ratio of 1.79 and a beta of 1.44. The company has a 50-day moving average of $15.84 and a two-hundred day moving average of $22.31. Progyny, Inc. has a 12-month low of $13.39 and a 12-month high of $42.08.

Progyny (NASDAQ:PGNY) last announced its earnings results on Tuesday, November 12th. The company reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.26). The business had revenue of $286.63 million for the quarter, compared to analyst estimates of $296.85 million. Progyny had a return on equity of 11.36% and a net margin of 5.03%. The business’s revenue was up 2.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.16 EPS. As a group, analysts forecast that Progyny, Inc. will post 0.58 EPS for the current fiscal year.

Analysts Set New Price Targets

PGNY has been the topic of several research reports. Truist Financial reissued a “hold” rating and set a $19.00 price objective (down from $26.00) on shares of Progyny in a research report on Wednesday, November 13th. Bank of America reduced their target price on shares of Progyny from $22.00 to $21.00 and set a “buy” rating for the company in a research note on Wednesday, November 13th. BTIG Research cut shares of Progyny from a “buy” rating to a “neutral” rating in a research note on Wednesday, August 7th. Leerink Partnrs cut shares of Progyny from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 7th. Finally, JPMorgan Chase & Co. reduced their target price on shares of Progyny from $31.00 to $22.00 and set an “overweight” rating for the company in a research note on Thursday, September 19th. Eight analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $25.42.

About Progyny

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.